Eli Lilly is set to acquire Kelonia Therapeutics for $3.25 billion upfront, aiming to strengthen its oncology and genetic medicines pipeline beyond its existing GLP-1 offerings.
Back
Quartz
Next Post
Microsoft to Invest $18 Billion in AI Infrastructure Across Australia
Related Posts
Customer Expectations Held Flat for Eleven Years. Patience Ran Out.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
How Enterprise Marketing Teams Are Using Neuromarketing Research to Win in Regulated Categories
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More